A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis
Sébastien Gibot(Centre Hospitalier Régional et Universitaire de Nancy), G Fauré(Université de Lorraine)
Cited by 364
Related Papers
Hydrocortisone in Severe Community-Acquired Pneumonia
|New England Journal of Medicine|2023|438
Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*
|Critical Care Medicine|2014|109
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
|Cellular and Molecular Immunology|2021|89
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
|The Lancet Respiratory Medicine|2023|76
sTREM-1 is a specific biomarker of TREM-1 pathway activation
|Cellular and Molecular Immunology|2021|75